231 related articles for article (PubMed ID: 191876)
41. The effect of carbacyclin, a prostaglandin analogue, on adenylate cyclase activity in platelet membranes.
Stein JM; Martin BR
FEBS Lett; 1984 Jan; 165(2):290-2. PubMed ID: 6363123
[TBL] [Abstract][Full Text] [Related]
42. Interrelationships between Ca2+ and adenylate and guanylate cyclases in the control of platelet secretion and aggregation.
Rodan GA; Feinstein MB
Proc Natl Acad Sci U S A; 1976 Jun; 73(6):1829-33. PubMed ID: 6960
[TBL] [Abstract][Full Text] [Related]
43. Inhibition of prostaglandin E1-responsive platelet adenylate cyclase by heparin: a study of the mechanism of inhibition and its relevance to platelet aggregation.
Amirrasooli H; Mac Neil S; Tomlinson S
Br J Pharmacol; 1981 Jul; 73(3):639-47. PubMed ID: 7248663
[TBL] [Abstract][Full Text] [Related]
44. Adenylate cyclase activation determines the effect of thromboxane synthase inhibitors on platelet aggregation in vitro. Comparison of platelets from responders and nonresponders.
Gresele P; Blockmans D; Deckmyn H; Vermylen J
J Pharmacol Exp Ther; 1988 Jul; 246(1):301-7. PubMed ID: 3134542
[TBL] [Abstract][Full Text] [Related]
45. Abnormality of adenylate cyclase regulation in human platelet membranes in renal insufficiency.
Jacobsson B; Ransnäs L; Nyberg G; Bergh CH; Magnusson Y; Hjalmarson A
Eur J Clin Invest; 1985 Apr; 15(2):75-81. PubMed ID: 2986984
[TBL] [Abstract][Full Text] [Related]
46. Drug stimulated prostacyclin release.
Weithmann KU
Ric Clin Lab; 1981; 11 Suppl 1():209-14. PubMed ID: 6324324
[TBL] [Abstract][Full Text] [Related]
47. Epoprostenol (prostacyclin, PGI2) binding and activation of adenylate cyclase in platelets of diabetic and control subjects.
Shepherd GL; Lewis PJ; Blair IA; de Mey C; MacDermot J
Br J Clin Pharmacol; 1983 Jan; 15(1):77-81. PubMed ID: 6342639
[TBL] [Abstract][Full Text] [Related]
48. Adenosine 5-diphosphate antagonists and human platelets: no evidence that aggregation and inhibition of stimulated adenylate cyclase are mediated by different receptors.
Cusack NJ; Hourani SM
Br J Pharmacol; 1982 May; 76(1):221-7. PubMed ID: 6282375
[TBL] [Abstract][Full Text] [Related]
49. Cyclic nucleotides and aggregation in platelets of spontaneously hypertensive rats.
Hamet P; Fraysse J; Franks DJ
Circ Res; 1978 Oct; 43(4):583-91. PubMed ID: 210976
[No Abstract] [Full Text] [Related]
50. Diminished platelet adenylate cyclase activation by prostaglandin D2 in acute thrombosis.
Cooper B
Blood; 1979 Sep; 54(3):684-93. PubMed ID: 380688
[TBL] [Abstract][Full Text] [Related]
51. Inhibition of human platelet adenylate cyclase by collagen fibres. Effect of collagen is additive with that of adrenaline, but interactive with that of thrombin.
Farndale RW; Winkler AB; Martin BR; Barnes MJ
Biochem J; 1992 Feb; 282 ( Pt 1)(Pt 1):25-32. PubMed ID: 1311555
[TBL] [Abstract][Full Text] [Related]
52. Multiple effects of guanine nucleotides on human platelet adenylated cyclase.
Tsai BS; Lefkowitz RJ
Biochim Biophys Acta; 1979 Sep; 587(1):28-41. PubMed ID: 486544
[TBL] [Abstract][Full Text] [Related]
53. Insensitivity of platelet adenylate cyclase to prostaglandin E1 in patients with hypokalemic diseases.
Güllner HG; Kafka MS; Gill JR
Ann Intern Med; 1984 Sep; 101(3):342-3. PubMed ID: 6540540
[No Abstract] [Full Text] [Related]
54. The antagonism by BW A868C of PGD2 and BW245C activation of human platelet adenylate cyclase.
Trist DG; Collins BA; Wood J; Kelly MG; Robertson AD
Br J Pharmacol; 1989 Feb; 96(2):301-6. PubMed ID: 2466517
[TBL] [Abstract][Full Text] [Related]
55. Lithium inhibits adenylate cyclase of human platelets.
Imandt L; Tijhuis D; Wessels H; Haanen C
Thromb Haemost; 1981 Apr; 45(2):142-5. PubMed ID: 6266068
[TBL] [Abstract][Full Text] [Related]
56. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
Maurice DH; Haslam RJ
Mol Pharmacol; 1990 May; 37(5):671-81. PubMed ID: 2160060
[TBL] [Abstract][Full Text] [Related]
57. 6-ketoprostaglandin E1 activates adenylate cyclase in human platelet membranes through prostacyclin receptors.
Oliva D; Nicosia S
Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 17():601-4. PubMed ID: 6328939
[No Abstract] [Full Text] [Related]
58. A simple assay for adenylate cyclase in intact cells by affinity elution chromatography.
Sinha AK; Colman RW
Biochem J; 1978 Sep; 174(3):699-702. PubMed ID: 215121
[TBL] [Abstract][Full Text] [Related]
59. On the interrelationship of prostaglandin endoperoxide G2 and cyclic nucleotides in platelet function.
Claesson HE; Malmsten C
Eur J Biochem; 1977 Jun; 76(1):277-84. PubMed ID: 195812
[TBL] [Abstract][Full Text] [Related]
60. Receptor-specific threshold effects of cyclic AMP are involved in the regulation of enzyme release and superoxide production from human neutrophils.
Lad PM; Goldberg BJ; Smiley PA; Olson CV
Biochim Biophys Acta; 1985 Aug; 846(2):286-95. PubMed ID: 2411298
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
